U.S. flag

An official website of the United States government

NM_006915.3(RP2):c.632G>A (p.Arg211His) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 6, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV005063027.1

Allele description [Variation Report for NM_006915.3(RP2):c.632G>A (p.Arg211His)]

NM_006915.3(RP2):c.632G>A (p.Arg211His)

Gene:
RP2:RP2 activator of ARL3 GTPase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp11.3
Genomic location:
Preferred name:
NM_006915.3(RP2):c.632G>A (p.Arg211His)
HGVS:
  • NC_000023.11:g.46854005G>A
  • NG_009107.1:g.22094G>A
  • NM_006915.3:c.632G>AMANE SELECT
  • NP_008846.2:p.Arg211His
  • NC_000023.10:g.46713440G>A
Protein change:
R211H
Links:
dbSNP: rs782164955
Molecular consequence:
  • NM_006915.3:c.632G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005727014Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 6, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Pathogenic mutations in retinitis pigmentosa 2 predominantly result in loss of RP2 protein stability in humans and zebrafish.

Liu F, Qin Y, Yu S, Soares DC, Yang L, Weng J, Li C, Gao M, Lu Z, Hu X, Liu X, Jiang T, Liu JY, Shu X, Tang Z, Liu M.

J Biol Chem. 2017 Apr 14;292(15):6225-6239. doi: 10.1074/jbc.M116.760314. Epub 2017 Feb 16.

PubMed [citation]
PMID:
28209709
PMCID:
PMC5391753

Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: genotype-phenotype correlations and impact on genetic counseling.

Pelletier V, Jambou M, Delphin N, Zinovieva E, Stum M, Gigarel N, Dollfus H, Hamel C, Toutain A, Dufier JL, Roche O, Munnich A, Bonnefont JP, Kaplan J, Rozet JM.

Hum Mutat. 2007 Jan;28(1):81-91.

PubMed [citation]
PMID:
16969763

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005727014.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: RP2 c.632G>A (p.Arg211His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 183390 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.632G>A has been reported in the literature in one individual affected with distinct retinal dystrophies, without primary information (Pelletier_2007). These report(s) do not provide unequivocal conclusions about association of the variant with Retinitis Pigmentosa, X-Linked. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant (Liu_2017). The following publications have been ascertained in the context of this evaluation (PMID: 28209709, 16969763). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 1, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search